Federal funding has played a vital role in cancer research, contributing approximately 57% of global funding from 2016-2020. This support has led to significant advancements in treatment, early detection, and survivorship. However, cuts to funding under the Trump administration are severely impacting universities like Harvard, Cornell, Northwestern, and Columbia, threatening future research and leaving families dealing with cancer diagnoses without hope. Statistics illustrate a decline in cancer deaths and improved survival rates, but the ongoing dismantling of research funding could reverse this progress, endangering lives and treatments.
Cancer treatment advances have been powered significantly by federally funded research, pivotal to transforming anecdotal experiences into tangible survivorship stories.
Cuts to university funding threaten the future of cancer care, jeopardizing hope for families facing diagnoses and undermining the research system essential for medical progress.
Collection
[
|
...
]